Short Interest in Defiance Daily Target 2X Long LMND ETF (NASDAQ:LMNX) Declines By 75.1%

Defiance Daily Target 2X Long LMND ETF (NASDAQ:LMNX) was the target of a large decline in short interest in May. As of May 15th, there was short interest totaling 13,175 shares, a decline of 75.1% from the April 30th total of 52,840 shares. Approximately 4.0% of the company’s stock are short sold. Based on an average trading volume of 28,873 shares, the days-to-cover ratio is presently 0.5 days.

Defiance Daily Target 2X Long LMND ETF Stock Down 1.1%

LMNX traded down $0.15 during trading on Friday, hitting $13.74. The company had a trading volume of 55,596 shares, compared to its average volume of 45,458. Defiance Daily Target 2X Long LMND ETF has a one year low of $10.81 and a one year high of $55.00. The company has a quick ratio of 6.08, a current ratio of 8.37 and a debt-to-equity ratio of 0.52. The firm’s 50-day moving average price is $16.21 and its 200 day moving average price is $25.65. The company has a market capitalization of $4.53 million, a PE ratio of 26.94 and a beta of -14.58.

About Defiance Daily Target 2X Long LMND ETF

Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide. Its products include Luminex 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; MAGPIX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids; MicroPlex, MagPlex, xTAG, SeroMAP, and calibration and control microspheres; xPONENT, a software suite to simplify laboratory workflow and enhance productivity; and TDAS, an analysis program designed for development and optimization of nucleic acid assays.